Zoetis Inc.

162.67
1.37 (0.85%)
At close: Mar 26, 2025, 3:59 PM
162.82
0.09%
After-hours: Mar 26, 2025, 04:34 PM EDT
0.85%
Bid 161.28
Market Cap 72.84B
Revenue (ttm) 9.13B
Net Income (ttm) 2.45B
EPS (ttm) 5.47
PE Ratio (ttm) 29.74
Forward PE 26.65
Analyst Buy
Ask 163.95
Volume 1,207,677
Avg. Volume (20D) 3,003,206
Open 161.44
Previous Close 161.30
Day's Range 160.68 - 163.47
52-Week Range 144.80 - 200.33
Beta 0.94

About ZTS

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respirat...

Sector Healthcare
IPO Date Feb 1, 2013
Employees 13,800
Stock Exchange NYSE
Ticker Symbol ZTS
Full Company Profile

Analyst Forecast

According to 9 analyst ratings, the average rating for ZTS stock is "Buy." The 12-month stock price forecast is $225, which is an increase of 38.32% from the latest price.

Stock Forecasts

Next Earnings Release

Zoetis Inc. is scheduled to release its earnings on May 1, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-4.49%
Zoetis shares are trading lower after Morgan Stanl... Unlock content with Pro Subscription
1 month ago
-5.15%
Zoetis shares are trading lower after the company issued FY25 guidance below estimates.